• Home
  • About
    • At a glance
    • Strategy & Business model
    • Team
    • Acknowledgements
    • Careers
    • Licensing
    • Investor & Press
      • Corporate profile
      • Press
  • Alzheimer´s disease
    • Alzheimer´s disease
    • Figures
    • Diagnosis
    • Prevention
  • Pipeline
  • Products
    • e4Risk®
    • e4Quant
    • AD Dementia Test
    • Degenerative Dementia test
  • Services
  • Patents & Publications
  • Quality
  • Contact
Biocross.es
  • Home
  • About
    • At a glance
    • Strategy & Business model
    • Team
    • Acknowledgements
    • Careers
    • Licensing
    • Investor & Press
      • Corporate profile
      • Press
  • Alzheimer´s disease
    • Alzheimer´s disease
    • Figures
    • Diagnosis
    • Prevention
  • Pipeline
  • Products
    • e4Risk®
    • e4Quant
    • AD Dementia Test
    • Degenerative Dementia test
  • Services
  • Patents & Publications
  • Quality
  • Contact
Select Page

Entrevista: Detectar el riesgo genético de padecer Alzheimer con un análisis de sangre

by Biocross | Jan 27, 2020 | News | 0 comments

Hoy por Hoy – Cadena SER | Angels Barceló

27/01/2020

https://biocross.es/wp-content/uploads/2020/04/Entrevista-Cadena-Ser-Angels-Barceló.mp3

Categories

  • News
  • Press release

Last News

  • Alzheimer: cuando el diagnóstico temprano marca la diferencia
  • El CREA participa en una investigación para evaluar un nuevo método de cribado de alzhéimer
  • DIÁLOGOS CERCO AL ALZHEIMER
All rights reserved BIOCROSS S.L. Spanish VAT number B-84250869.